Capitalizing on the Skin Laxity Surge

The rise of GLP-1 medications like Ozempic has created a fast-growing new category of aesthetic demand: post-weight-loss skin laxity. Now the question is — is your practice ready to meet it?

Join Monarch Aesthetic Services on May 27 at 5:00 PM PST for a live webinar, From Ozempic to Opportunity: Capitalizing on the Skin Laxity Surge, featuring Erin Borini, MS, PA-C and Kristin Gemme, PA-C.